Blog

Oct 23, 2024, 13:03

Corinne Faivre-Finn: Mentoring opportunity for radiation oncologists in lung cancer

Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at the University of Manchester, shared the following post on LinkedIn:

“Exciting Opportunity for Radiation and Clinical Oncologists Specialising in Lung Cancer!

The ESTRO Lung Cancer Focus Group, in collaboration with the ESTRO Young Committee, is launching a specialised mentoring program tailored for radiation and clinical oncologists passionate about thoracic malignancies. This unique initiative aims to nurture the next generation of clinical leaders in thoracic radiation oncology.

Why Join?

Skill Development: Gain expertise through one-on-one mentorship.
Career Planning: Set clear goals and expand your network.
Emotional Support: Share your ambitions, challenges, and successes with your mentor.

Program Highlights:

Kickoff (Jan 2025 – April 2025): Three online sessions covering mentorship basics, career planning, research, and work-life balance.
Mentor-Mentee Match (April 2025): Meet your mentor at the ESTRO 2025 Annual Meeting in Vienna.
Monthly Interaction: 20 months of personalized 1:1 meetings with continued support through online group discussions.

Looking for Mentees & Mentors:

Mentees: Early-career radiation oncologists (within 10 years of residency) with a keen interest in thoracic oncology.
Mentors: Experienced radiation oncologists (10+ years post-residency) with expertise in thoracic malignancies and a passion for guiding the next generation.
Ready to make an impact? Whether you’re seeking guidance or ready to inspire, this program offers a rewarding opportunity for personal and professional growth.

Join us today—scan the QR code to register as a mentor or mentee-see attached flyer.”

cancer clinical oncology Corinne Faivre-Finn ESTRO healthcare Lung cancer mentoring program OncoDaily Oncology radiation oncology thoracic malignancies

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage